At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 45 enrolled
Drug / intervention
Arginine/Calcium Carbonate +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Efficacy of 10% Arginine Bicarbonate Prophylaxis Paste
In Brief
A Phase 3 clinical trial evaluating Arginine/Calcium Carbonate and Nupro - Fluoride Free for Hypersensitivity. Completed, enrolled 45 participants across 1 site.
Detailed Summary
The objective of this study is to evaluate the clinical efficacy of a prophylaxis paste containing 10% arginine bicarbonate on dentinal hypersensitivity reduction when applied as a pre-procedure to a professional dental cleaning.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypersensitivity
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2008
Primary CompletionAug 2008
First PostedFeb 2010
TodayJul 2026
First PostedFeb 19, 2010
Enrollment StartJul 1, 2008
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 16.4 years ago
Interventions
Arginine/Calcium Carbonatedevice
One time treatment
Nupro - Fluoride Freedevice
Brush twice daily